Stuart Schnitt, MD, chief of Breast Oncologic Pathology at Dana-Farber Brigham Cancer Center, discusses pathology reports at the second annual Ductal Carcinoma In Situ Patient Forum May 18, 2024.
To learn more about the DCIS Program, visit us at https://www.dana-farber.org/cancer-care/treatment/breast-oncology/programs/ductal-carcinoma-in-situ